Differences in blood lipid concentrations between fluvastatin and placebo treatment groups at the end of the study
| Unstable angina | Stable angina | |||||||
|---|---|---|---|---|---|---|---|---|
| Fluvastatin (n = 417) | Placebo (n = 407) | Fluvastatin (n = 418) | Placebo (n = 416) | |||||
| Concentration (mmol/) | Change from baseline | Concentration (mmol/l) | Change from baseline | Concentration (mmol/l) | Change from baseline | Concentration (mmol/l) | Change from baseline | |
| Total cholesterol | −0.65 | −12.6% | 0.10 | 1.9% | −0.62 | −11.9% | 0.03 | 0.6% |
| LDL cholesterol | −0.79 | −23.0% | −0.04 | −1.2% | −0.76 | −22.4% | −0.09 | −2.6% |
| HDL cholesterol | 0.21 | 22.1% | 0.22 | 23.2% | 0.17 | 17.0% | 0.21 | 21.4% |
| Triglycerides | −0.15 | −8.6% | −0.15 | −8.6% | −0.11 | −6.3% | −0.17 | −9.9% |